The kinase(s) responsible for AMPK-αSer485 have not been extensively studied, although both insulin and hepatitis C have been reported to inhibit AMPK activation by mediating phosphorylation of this site by Akt/PKB [37], [38]. The gene discussed is PRKAA2; the disease is hepatitis C virus infection.